Study guide
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders
Nutritionist-Dietitian Licensure Examination NDLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian
1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets
2 Chapter 2: Anatomy and Physiology for Nutrition I
2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite
3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism
3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways
4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry
4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance
5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI
5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines
6 Chapter 6: Diet Computation and Clinical Nutrition Assessment
6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment
7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data
7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment
8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders
8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight
9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease
9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract
10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders
11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition
11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults
12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition
12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications
13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling
13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories
14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition
14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs
15 Chapter 15: Community Nutrition and Population Assessment
15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)
16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance
16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System
17 Chapter 17: Nutrition Education and Program Evaluation
17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation
18 Chapter 18: Program Planning, Interventions, and Food Security
18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations
19 Chapter 19: Nutrition Governance, Networking, and Program History
19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems
20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws
20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions
21 Chapter 21: Nutrition in the Life Cycle I
21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs
22 Chapter 22: Nutrition in the Life Cycle II
22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs
23 Chapter 23: Food Science and Plant Foods
23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery
24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods
24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques
25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality
25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production
26 Chapter 26: Food Microbiology, Preservation, and Food Law
26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling
27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety
27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service
28 Chapter 28: Food Service Systems, Production Planning, and Menus
28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization
29 Chapter 29: Distribution, Purchasing, and Storage
29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation
30 Chapter 30: Cost Control, Financial Management, and Facility Layout
30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics
31 Chapter 31: Equipment, Management, and Human Resources
31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline
32 Chapter 32: Labor Law, Permits, and Food Service Marketing
32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders
Key Takeaways Explain This Topic AI
In liver cirrhosis, chronic dietary protein restriction is obsolete and harmful; patients require 1.2 – 1.5 g/kg/day 1.2–1.5\text{ g/kg/day} 1.2–1.5 g/kg/day of protein, 30 – 35 kcal/kg/day 30–35\text{ kcal/kg/day} 30–35 kcal/kg/day , a 2,000 mg/day 2{,}000\text{ mg/day} 2 , 000 mg/day sodium limit for ascites, and a mandatory late-evening bedtime snack to prevent accelerated nocturnal muscle proteolysis.
In acute pancreatitis, early enteral nutrition via nasogastric or nasojejunal access within 24–48 hours preserves gut mucosal integrity; chronic pancreatitis manages exocrine insufficiency with Pancreatic Enzyme Replacement Therapy (PERT) taken with all meals without unnecessary fat restriction.
In cirrhosis with ascites, sodium is limited to about 2,000 mg/day, and fluid is restricted only when serum sodium falls below about 125 mEq/L.
Hepatic encephalopathy is treated medically with lactulose and rifaximin; protein is not routinely restricted, and vegetable and dairy protein or BCAA supplements are options for the few patients who do not tolerate meat protein.
Last updated: October 2026
The liver, gallbladder, and exocrine pancreas complete digestion and coordinate intermediary metabolism. Their diseases are high-yield because older restrictive diets have been replaced by evidence-based practice.
- Hepatic Disorders
- 1. Liver Cirrhosis and End-Stage Liver Disease
Cirrhosis is characterized by diffuse fibrosis and the conversion of normal hepatic architecture into abnormal regenerative nodules, leading to portal hypertension , ascites, esophageal varices, and hepatic encephalopathy.
2. Evidence-Based MNT for Cirrhosis
Energy Requirements: 30 − 35 kcal/kg/day 30 - 35\text{ kcal/kg/day} 30 − 35 kcal/kg/day (based on dry, edema-free body weight) to meet hypermetabolic demands and prevent tissue wasting.
Protein Requirements: 1.2 − 1.5 g/kg/day 1.2 - 1.5\text{ g/kg/day} 1.2 − 1.5 g/kg/day dry weight .
Important
Reversal of the Obsolete Protein Restriction Dogma in Cirrhosis: Historically, dietitians restricted dietary protein in cirrhotic patients to prevent hepatic encephalopathy. Severe or chronic protein restriction is obsolete, dangerous, and directly harmful. Cirrhotic patients experience severe protein-energy wasting and skeletal muscle breakdown ( sarcopenia ). Skeletal muscle is the primary secondary organ that detoxifies ammonia into glutamine via glutamine synthetase. Depleting skeletal muscle mass through protein restriction paradoxically impairs systemic ammonia clearance and accelerates hepatic encephalopathy! Patients must receive 1.2 to 1.5 g/kg/day of protein.
The Late-Evening Bedtime Snack: Cirrhotic patients experience accelerated starvation . Due to depleted hepatic glycogen stores and impaired gluconeogenesis, an overnight fast in a cirrhotic patient produces the metabolic equivalent of 72 hours of starvation in a healthy individual, triggering massive skeletal muscle proteolysis and fat oxidation. Providing a mandatory late-evening snack (200 to 300 kcal) containing complex carbohydrates and protein (e.g., cereal with milk, whole-wheat sandwich) suppresses overnight gluconeogenesis, preserves muscle mass, and improves nitrogen balance.
Ascites Management: Enforce a dietary sodium restriction of 2,000 mg/day 2{,}000\text{ mg/day} 2 , 000 mg/day ( 88 mEq/day 88\text{ mEq/day} 88 mEq/day ). Fluid restriction ( 1.0 − 1.5 L/day 1.0 - 1.5\text{ L/day} 1.0 − 1.5 L/day ) is indicated only if severe dilutional hyponatremia is present (serum sodium < 125 mEq/L < 125\text{ mEq/L} < 125 mEq/L ).
Esophageal Varices: Prescribe a soft, low-roughage diet; avoid sharp, coarse, scratchy foods (e.g., hard crackers, raw chips) that can mechanically injure vulnerable varices and precipitate catastrophic hemorrhage.
Hepatic Encephalopathy (HE): The primary treatment is medical ( lactulose , which acidifies the colonic lumen to convert absorbable N H 3 NH_3 N H 3 into unabsorbable ammonium N H 4 + NH_4^+ N H 4 + , and non-absorbable antibiotics like rifaximin). Maintain dietary protein at 1.2 to 1.5 g/kg/day. In the minority of patients with true, documented episodic protein intolerance, temporary substitution with vegetable and dairy protein sources (which are naturally higher in Branched-Chain Amino Acids [BCAA: leucine, isoleucine, valine] and lower in Aromatic Amino Acids [AAA: phenylalanine, tyrosine, tryptophan] ) or supplementation with specialized BCAA formulas should be initiated.
- Pancreatic and Biliary Disorders
- 1. Acute Pancreatitis
Pathophysiology: Premature intrapancreatic activation of digestive zymogens (especially trypsinogen to trypsin), resulting in autodigestion of pancreatic parenchyma, severe inflammation, and vascular leakage. Gallstones and heavy alcohol abuse account for > 80 % > 80\% > 80% of cases.
MNT Guidelines:
Mild Acute Pancreatitis: Traditional prolonged NPO is unnecessary. Initiate early oral feeding as soon as abdominal pain subsides and ileus resolves, using an easily digestible, low-fat solid or soft diet (low-fat diets reduce cholecystokinin release and postprandial pancreatic stimulation). There is no need to wait for serum lipase/amylase to normalize before feeding.
Severe Acute Pancreatitis: Early Enteral Nutrition (EN) initiated within 24 to 48 hours is significantly superior to Total Parenteral Nutrition (TPN), reducing multi-organ failure, systemic infections, and mortality by preserving gut mucosal barrier integrity and preventing bacterial translocation. Continuous feeding via a nasojejunal (NJ) tube placed past the ligament of Treitz minimizes pancreatic stimulation; however, standard nasogastric (NG) feeding is equally effective and well-tolerated in many clinical settings.
2. Chronic Pancreatitis
Pathophysiology: Irreversible, progressive destruction of pancreatic exocrine and endocrine tissue with fibrous replacement. Loss of > 90 % > 90\% > 90% of exocrine secretory capacity produces pancreatic exocrine insufficiency (PEI) , resulting in severe fat malabsorption, steatorrhea (fecal fat excretion > 7 g/24 hours > 7\text{ g/24 hours} > 7 g/24 hours ), azotorrhea, and weight loss.
MNT Guidelines:
Pancreatic Enzyme Replacement Therapy (PERT): Prescribe high-potency, enteric-coated microencapsulated lipase enzymes (e.g., pancrelipase) that must be taken with every meal and snack . Enteric coatings protect enzymes from gastric acid denaturation, dissolving at duodenal pH > 5.5 \text{pH } > 5.5 pH > 5.5 .
Dietary Fat Intake: High-energy diet ( 35 kcal/kg/day 35\text{ kcal/kg/day} 35 kcal/kg/day ), high-protein ( 1.2 − 1.5 g/kg/day 1.2 - 1.5\text{ g/kg/day} 1.2 − 1.5 g/kg/day ). Clinical Practice Rule: Do NOT restrict dietary fat unless steatorrhea is unmanageable despite maximum PERT dosing. Unnecessary fat restriction severely exacerbates caloric deficits and protein-energy wasting.
Micronutrient Repletion: Fat-soluble vitamins ( Vitamins A, D, E, and K ) in water-miscible formulations; monitor Vitamin B 12 B_{12} B 12 (pancreatic proteases are needed to cleave R-protein from B 12 B_{12} B 12 in the duodenum to allow binding to intrinsic factor).
Strict Abstinence: Complete, lifelong cessation of all alcohol and tobacco use.
3. Cholecystitis and Cholelithiasis
Pathophysiology: Gallstones (cholelithiasis) obstructing the cystic duct, causing chemical and bacterial inflammation of the gallbladder (cholecystitis).
MNT Guidelines: During acute symptomatic episodes, prescribe a strict low-fat diet ( < 20 − 30 g fat/day < 20 - 30\text{ g fat/day} < 20 − 30 g fat/day or < 25 % < 25\% < 25% of total calories) to minimize cholecystokinin (CCK) secretion and suppress painful gallbladder contractions. Following cholecystectomy, bile flows continuously from the liver into the duodenum; patients should follow a low-fat diet initially, gradually advancing to normal dietary fat intake as the small intestine adapts.